Last reviewed · How we verify

Phloroglucin — Competitive Intelligence Brief

Phloroglucin (Phloroglucin) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Other.

marketed Beta-secretase 1 Other Small molecule Live · refreshed every 30 min

Target snapshot

Phloroglucin (Phloroglucin) — Ajou University School of Medicine.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Phloroglucin TARGET Phloroglucin Ajou University School of Medicine marketed Beta-secretase 1
Donepezil (Aricept) Donepezil (Aricept) University of Virginia marketed Acetylcholinesterase Inhibitor Beta-secretase 1, Multidrug resistance protein 1, Acetylcholine receptor subunit epsilon
Aricept Aricept Eisai Korea Inc. marketed Beta-secretase 1, Multidrug resistance protein 1, Acetylcholine receptor subunit epsilon

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Phloroglucin — Competitive Intelligence Brief. https://druglandscape.com/ci/phloroglucin. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: